MLIRF.PA Innovative Rfk SpA
- Market cap
- EUR 16.4M
- P/E
- 12.0x
- P/B
- 1.27x
- ROE
- 10.8%
- Dividend yield
- -
- Fundamental score
- 2.3/5
Ratios use the latest price and the fiscal year ending Dec 2025.
Is MLIRF.PA undervalued?
Graham numberMLIRF.PA trades 17.8% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Innovative Rfk SpA fundamental analysis
5 of 11 checks passedROE 1/2
The stock's ROE falls within an average range (14.89%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.
ROA 2/2
This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.
PBV 2/2
With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.
DER 2/2
The stock has a low debt to equity ratio (12%), which means it has a small amount of debt compared to the ownership it holds
Revenue Growth 0/2
Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.
Net Profit Growth 0/2
This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.
Assets Growth 2/2
With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.
Graham Number 0/1
Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.
Dividend Growth 0/2
The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.
Dividend 0/2
Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.
Buffet Intrinsic Value 0/1
The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Innovative Rfk SpA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Innovative Rfk SpA
Innovative-RFK S.p.A. is a private equity firm specializing in growth capital investments in Small and Medium sized companies. The firm prefers to make small cap buy-outs. The firm also makes fund of fund investments in private equity funds. It prefers to invest in the biomedical systems, microcredit for SMEs, information technology, high tech sector, and innovative solutions for different industries. It typically invests in companies based in Italy. It invests up to "3 mill…
Full company profileInnovative Rfk SpA financial statements
Innovative Rfk SpA annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 8.00K | 17.2K | 195K | 133K | 50.5K | 119K | 131K | 255K | 388K |
| Gross Profit | 3.90K | -100K | -190K | 133K | -375K | 111K | 39.3K | 156K | 142K |
| Operating Income | 3.90K | 7.07K | 28.5K | -249K | -383K | 2.14M | -825K | -891K | -394K |
| EBITDA | 3.18K | 13.7K | 28.8K | -247K | -387K | 2.04M | -731K | 1.27M | -387K |
| Net Income | 852.00 | 2.77K | 7.39K | -301K | -343K | 1.93M | -841K | 1.16M | 1.39M |
| EPS | 0.00 | 0.00 | 0.00 | -0.03 | -0.04 | 0.15 | -0.06 | 0.09 | 0.15 |
| Balance Sheet | |||||||||
| Total Assets | 2.86M | 6.89M | 9.38M | 11.3M | 12.3M | 17.6M | 16.6M | 15.3M | 14.2M |
| Total Liabilities | 249K | 469K | 160K | 1.47M | 1.97M | 1.93M | 1.96M | 2.00M | 1.28M |
| Shareholders' Equity | 2.61M | 6.42M | 9.22M | 9.84M | 10.3M | 15.6M | 14.7M | 13.3M | 12.9M |
| Cash & Short-term Investments | 29.4K | 200K | 1.39M | 2.08M | 1.60M | 7.60M | 664K | 129K | 973K |
| Total Debt | 240K | 448K | 56.6K | 1.35M | 1.85M | 1.85M | 1.82M | 1.82M | 1.16M |
| Cash Flow | |||||||||
| Operating Cash Flow | 13.2K | -91.0K | -274K | -267K | -155K | -394K | -457K | 484K | -650K |
| Capital Expenditure | 10.3K | 14.3K | 0.00 | 10.8K | 13.6K | 1.84K | 7.27K | 3.92K | 6.72K |
| Free Cash Flow | 13.2K | -105K | -274K | -278K | -155K | -396K | -464K | 480K | -657K |
| Ratios | |||||||||
| ROE | 0.0% | 0.0% | 0.1% | -3.1% | -3.3% | 12.4% | -5.7% | 8.7% | 10.8% |
| ROA | 0.0% | 0.0% | 0.1% | -2.7% | -2.8% | 11.0% | -5.1% | 7.6% | 9.8% |
| Net Profit Margin | 10.7% | 16.2% | 3.8% | -226.4% | -680.1% | 1,624.0% | -643.0% | 455.6% | 359.0% |
| Debt to Equity | 0.09x | 0.07x | 0.01x | 0.14x | 0.18x | 0.12x | 0.12x | 0.14x | 0.09x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Innovative Rfk SpA dividends
Innovative Rfk SpA has not paid dividends in the last 9 fiscal years.
Who owns Innovative Rfk SpA
- Insiders 0.00%
- Institutions 2.04%
- Public & others 97.96%
- Shares outstanding 9.09M
- Free float 4.21M
Innovative Rfk SpA company profile
- Company name
- Innovative Rfk SpA
- Ticker
- MLIRF.PA
- ISIN
- IT0005391161
- Exchange
- Euronext Paris
- Sector
- Financial Services
- Industry
- Capital Markets
- Employees
- 2
- Fiscal year end
- December
- Address
- Via del Carmine 11, Milan, Italy, 20122
- Phone
- 39 02 98670065
- Website
- innovative-rfk.it
About Innovative Rfk SpA
Innovative-RFK S.p.A. is a private equity firm specializing in growth capital investments in Small and Medium sized companies. The firm prefers to make small cap buy-outs. The firm also makes fund of fund investments in private equity funds. It prefers to invest in the biomedical systems, microcredit for SMEs, information technology, high tech sector, and innovative solutions for different industries. It typically invests in companies based in Italy. It invests up to "3 million ($3.54 million) in companies with enterprise value up to "50 million ($58.96 million), sales value up to "50 million ($58.96 million) and EBITDA up to "5 million ($5.9 million). The firm invests through its personal capital. The firms can hold either minority or majority stake in its portfolio. The firm prefers to exit its investments within 18-24 months through IPO. Innovative-RFK S.p.A. was founded in 2017 and it is based in Milan, Italy.
Innovative Rfk SpA management
10- Mr. Antonello CarlucciChief Executive Officer
- Mr. Massimo LaccisagliaCo-Founder & Vice President of Board of Directors
- Mr. Paolo PescettoFounder & President · born 1969
- Mr. Andrea RossottiCo-Founder · born 1980
- Mr. Ernesto PaolilloSenior Advisor & Strategic Advisor · born 1946
- Mr. Piero D'AgriSenior Advisor of Health
- Mr. Gianluigi TestaSenior Advisor of ESG
- Mr. Michele SibioAssociate
- Mr. Kristian LugaràSenior Analyst
- Mr. Lorenzo LavecchiaAnalyst